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Abstract
Background: Inflammation and immune responses are considered to be very important in the
pathogenesis of atherosclerosis. Lipid accumulation in macrophages of the arterial intima is a
characteristic feature of atherosclerosis which can influence the inflammatory potential of
macrophages. We studied the effects of lipid loading on the regulation of TNF expression in human
monocyte-derived macrophages.
Results: In macrophages incubated with acetylated low density lipoprotein (ac-LDL) for 2 days,
m R N A  e x p r e s s i o n  o f  T N F  i n  c e l l s  s t i m u l a t e d  w i t h  T N F  d e c r e a s e d  b y  7 5 % .  I n  c e l l  c u l t u r e s
stimulated over night with IL-1β, lipid loading decreased secretion of TNF into culture medium by
48%. These results suggest that lipid accumulation in macrophages makes them less responsive to
inflammatory stimuli. Decreased basal activity and inducibility of transcription factor AP-1 was
observed in lipid-loaded cells, suggesting a mechanism for the suppression of cytokine expression.
NF-κB binding activity and inducibility were only marginally affected by ac-LDL. LDL and ac-LDL
did not activate PPARγ. In contrast, oxidized LDL stimulated AP-1 and PPARγ but inhibited NF-κB,
indicating that the effects of lipid loading with ac-LDL were not due to oxidation of lipids.
Conclusions:  Accumulation of lipid, mainly cholesterol, results in down-regulation of TNF
expression in macrophages. Since monocytes are known to be activated by cell adhesion, these
results suggest that foam cells in atherosclerotic plaques may contribute less potently to an
inflammatory reaction than newly arrived monocytes/macrophages.
Background
Lipid accumulation in macrophages leads to formation of
foam cells, a distinct cell type found in fatty streaks and
more advanced atherosclerotic lesions. Apart from effects
on cellular lipid metabolism, the effects of intracellular li-
pid accumulation on gene expression have not been ex-
tensively studied. Since uptake of low density lipoprotein
(LDL) is subject to negative feedback control of the LDL
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receptor pathway, we chose to incubate cells with acetylat-
ed LDL (ac-LDL), which is taken up by the scavenger re-
ceptors. In this way, a more efficient lipid loading is
achieved.
Lipid loading with ac-LDL in phorbol myristate acetate
(PMA)-pretreated THP-1 macrophages has been reported
to increase production of interleukin-8 (IL-8) and mono-
cyte chemotactic protein-1 (MCP-1) [1]. It was further
shown that IL-8 mRNA is expressed in a macrophage-rich
area of the human atheromatous lesion [1]. In natural
killer (NK) cells, very low density lipoprotein (VLDL) and
ac-LDL decreased secretion of granulocyte-macrophage
colony stimulating factor (GM-CSF) [2]. In non-primed
NK cells, these lipoproteins stimulated IL-8 secretion, but
in NK cells primed with IL-2, secretion of IL-8 decreased,
indicating that the differentiation state of the cell or other
factors can influence the response of cells to lipoproteins
[2]. Ac-LDL has also been demonstrated to decrease the
secretion of platelet-derived growth factor from endothe-
lial cells [3].
In order to understand the interactions between three im-
portant aspects of atherosclerosis, macrophages, lipid ac-
cumulation and inflammation, we studied the effects of
ac-LDL on the expression of TNF in human monocyte-de-
rived macrophages.
Results
Lipid loading decreases TNF expression
The effect of lipid loading on TNF protein secretion was
determined in the following way: Human monocyte-de-
rived macrophages were incubated in medium containing
5% lipoprotein-deficient serum (LPDS) with or without
ac-LDL (50 µg/mL) for 2 days, washed, and incubated in
serum-free medium without GM-CSF for 24 h. Immedi-
ately after the treatment with ac-LDL, IL-1β (10 ng/mL)
was added to some dishes to induce secretion of TNF. Cul-
ture medium was collected and analysed for TNF by ELI-
SA. In three separate experiments, TNF levels in culture
medium were 48% ± 13% (mean ± SEM) lower in lipid-
loaded cells than in control cells incubated with LPDS
only (Table 1).
Next, we analysed the effect of lipid loading on TNF
mRNA expression. Macrophages were loaded with lipid
by incubation with ac-LDL (50 µg/mL) in medium con-
taining 5% LPDS for 2 days. The cells were then harvested
and mRNA was isolated for northern blotting. Lipid load-
ing did not increase the very low or undetectable basal
TNF mRNA levels (Figure 1, lanes 1 and 3). We also stud-
ied the effects of lipid loading on the inducibility of TNF
mRNA expression. Macrophages were stimulated with
TNF, which is known to stimulate its own synthesis [4]. In
lipid-loaded macrophages, TNF-inducible TNF mRNA ex-
pression decreased by 75% (Figure 1, lanes 2 and 4), as
compared to macrophages incubated in the presence of
5% LPDS only, followed by TNF stimulation.
The effect of lipid loading on transcription factors
In order to identify transcription factors involved in the
regulation of TNF expression by lipid loading, we per-
formed electrophoretic mobility shift assays. NF-κB bind-
ing activity was not substantially influenced by
incubation of macrophages with ac-LDL for 48 h (Figure
2). By contrast, lipid loading diminished both basal and
TNF-induced activation of AP-1 (Figure 2). Based on den-
sitometric scanning of the autoradiograph, the decrease
was 67% for basal activity and 74% for TNF-induced
binding activity. Incubation with LDL also resulted in re-
duced AP-1 activity (Figure 3, lanes 6 and 7), but LDL was
less potent than ac-LDL in this respect, most probably be-
cause LDL is not taken up as effectively as ac-LDL by mac-
rophages. As determined by phosphorimager analysis,
LDL treatment reduced AP-1 binding in unstimulated
cells by 57%, and in TNF-stimulated cells by 58%. Corre-
sponding values for ac-LDL-treated cells in this experi-
ment were 78% and 71%, respectively, as compared to
cells treated with LPDS only.
We also incubated macrophages with oxidized LDL (ox-
LDL) to test if the effects of ac-LDL could be due to oxida-
tion of LDL. Ox-LDL enhanced AP-1 binding activity (Fig-
ures 3 and 4), in accordance to our previous studies
showing a similar effect in human adherent monocytes
[5] and smooth muscle cells [6]. In cells not stimulated
with TNF, AP-1 binding increased by 43% (Figure 3, lane
10) to 275% (Figure 4), while in TNF-stimulated cells the
ox-LDL-induced increase ranged from 52% (Figure 3, lane
Table 1: IL-1β-induced TNF secretion is decreased in lipid-loaded 
macrophages
TNF concentration (pg/mL)
Treatment Experiment 1 Experiment 2 Experiment 3
LPDS 5.9 5.4 6.4
LPDS + IL-1β 14.2 165.3 23.0
Ac-LDL 5.5 5.6 5.4
Ac-LDL + IL-1β 8.4 54.5 14.6
Inhibition 41% 67% 36%
Macrophages were incubated for 48 h in the presence of 5% LPDS ± 
50 µg/mL ac-LDL. They were then rinsed with serum-free medium, 
and incubated for 24 h in serum-free medium with or without IL-1β 
(10 ng/mL). Culture medium was collected, centrifuged at 4000 g for 
10 min, and aliquots of the supernatant were frozen for analysis of 
secreted TNF by ELISA.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/13
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11) to 242% (Figure 4). When the same nuclear extracts
were analysed for NF-κB binding activity, it was seen that
ox-LDL inhibited both basal (69% decrease) and TNF-in-
duced (57% decrease) DNA binding activity of NF-κB
(Figure 4). We have previously demonstrated the same ef-
fect in smooth muscle cells stimulated with LPS [6]. LDL
which had been stored at 4°C for 4 weeks without EDTA
('Old LDL'), had a weak inhibitory effect on NF-κB, and a
weak stimulatory effect on AP-1 (Figure 4), indicating that
even partially oxidized LDL stimulates AP-1. Since lipid
loading with fresh ac-LDL or LDL did not inhibit NF-κB,
it appears that the lipoproteins were not oxidized to a sig-
nificant degree during the treatments. Taken together, the
results indicate that the inhibitory effect of lipid loading
on AP-1 was primarily due to uptake of non-oxidized li-
poproteins.
Specificity assays demonstrated that NF-κB1 (p50) and
RelA (p65) were the major subunits in NF-κB activated by
stimulation with TNF (Figure 5). For AP-1, c-Jun and JunD
were among the most abundant subunits (Figure 6).
Since ox-LDL is known to activate the anti-inflammatory
transcription factor PPAR-γ [7], we tested whether ac-LDL
treatment activates this transcription factor. While ox-LDL
treatment (100 µg/mL, 2 h) stimulated PPAR-γ binding
activity, LDL and ac-LDL either had no effect or weakly
suppressed PPAR-γ (Figure 7). Similar effects have been re-
ported elsewhere [7], despite the fact that many fatty acids
and fatty acid derivatives activate PPARs [8–10]. Shorter
treatments (4 h) with LDL, ac-LDL, and VLDL had similar
effects (data not shown) confirming the suppressive effect
of lipid loading on AP-1 was not due to activation of
PPAR-γ, and added further support to the notion that lipo-
proteins were not oxidized to any significant degree dur-
ing the treatments.
Discussion
In the present study, we have shown that uptake of ac-LDL
by macrophages leads to reduced inducibility of TNF ex-
pression. Suppression of cytokine expression was associat-
ed with reduced basal and stimulated DNA binding
activity of AP-1, a transcription factor known to regulate
TNF expression. Even though NF-κB has been shown to
Figure 1
Decreased inducibility of TNF mRNA in macrophages incu-
bated with ac-LDL. Macrophages were cultured for 48 h in
the presence of 5% LPDS ± 50 µg/mL ac-LDL. Half of the
dishes were then stimulated with TNF (10 ng/mL) for 2 h.
TNF mRNA was analysed by Northern blotting, using β-actin
as loading control. Lanes: 1, Control; 2, TNF; 3, ac-LDL; 4,
ac-LDL + TNF. Data are representative of three separate
experiments.
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Figure 2
Lipid loading does not decrease inducibility of NF-κB but
inhibits AP-1. Macrophages were cultured for 48 h in the
presence of 5% LPDS ± 50 µg/mL ac-LDL. The cells were
then stimulated with TNF (10 ng/mL) for 2 h. Nuclear
extracts were prepared and transcription factor activities
(lanes 1–5, NF-κB; lanes 6–10, AP-1) were determined in the
extracts. The arrowheads indicate the positions of specific
complexes. Lanes: 1 and 6, probe only; 2 and 7, control; 3
and 8, TNF; 4 and 9, ac-LDL; 5 and 10, ac-LDL + TNF. Similar
results were obtained in five independent experiments.
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regulate the expression of TNF, there are a number of re-
ports [4,11,12] suggesting that AP-1 sites are more impor-
tant for the activation of this gene. AP-1 has been
implicated in the transcriptional regulation of several oth-
er cytokines as well, including IL-1β [13], IL-2 [14], IL-3
[15], IL-6 [16], colony-stimulating factor-1 [17], and
transforming growth factor β1 [18]. Our results suggest
that AP-1 is important for the expression of TNF, even in
the presence of high levels of active NF-κB.
LDL oxidized in the presence of Cu2+ or Fe2+ has been
shown to inhibit LPS or maleylated BSA-induced expres-
sion of TNF and IL-1α mRNA in mouse peritoneal macro-
phages [19]. In the same study, LDL and ac-LDL
suppressed LPS-induced expression of inflammatory cy-
tokines, but the authors thought that these effects could
have been due to oxidation of lipoproteins. In the present
study, we have shown that ox-LDL and ac-LDL have differ-
ent effects on the transcription factors NF-κB, AP-1 and
PPARγ, indicating that the suppression of cytokine expres-
sion by ac-LDL was not due to oxidation of lipoproteins.
Inhibition of NF-κB by oxidized lipoproteins has been
demonstrated in several studies [6,20–22]. Other groups
[23–26] have reported stimulatory effects. In another
study [27], ox-LDL was shown to inhibit NF-κB after long
(>20 h) incubations, even though a stimulatory effect was
reported for short treatments (4 h). Our data from exper-
iments with macrophages and smooth muscle cells sug-
gests that oxidized LDL inhibits NF-κB during short
treatments as well, but we can not completely exclude the
possibility that some preparations of LDL or ox-LDL
might be stimulatory. Inhibition of NF-κB by ox-LDL
could attenuate the inflammatory response to oxidized li-
pids, but it could also make cells more susceptible to ap-
optosis [28], which in vascular context has been shown to
induce inflammation [29]. In any case, the consistent ac-
tivation of AP-1 by ox-LDL in macrophages and in smooth
muscle cells [6] indicates that AP-1 may in some cases be
more important for the direct inflammatory effects of ox-
LDL than NF-κB.
Figure 3
Comparison of the effects of different lipoproteins on AP-1.
Macrophages were cultured for 48 h in serum-free medium
(SF, lanes 2–3) or in the presence of 5% LPDS ± 50 µg/mL
LDL or 50 µg/mL ac-LDL. Half of the dishes were then stim-
ulated with TNF (10 ng/mL) for 2 h. Some dishes were
treated for 2 h with ox-LDL (100 µg/mL) before addition of
TNF. EMSA was performed as described in methods. The
arrowhead indicates the position of AP-1 specific complexes.
Lanes: 1, probe only; 2, SF; 3, SF + TNF; 4, Control (5%
LPDS); 5, TNF; 6, LDL; 7, LDL + TNF; 8, ac-LDL; 9, ac-LDL +
TNF; 10, ox-LDL; 11, ox-LDL + TNF. Data are representa-
tive of three independent experiments.
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Figure 4
Effects of ox-LDL on NF-κB and AP-1 binding activity. Mac-
rophages were incubated for 48 h in serum-free medium
without GM-CSF and subsequently treated for 2 h with cop-
per-oxidized LDL (ox-LDL, 100 µg/mL) or LDL stored for
one month at 4°C without EDTA (old LDL, 100 µg/mL). Half
of the cells were simultaneously stimulated with TNF (10 ng/
mL). The same nuclear extracts were analysed for NF-κB
(grey bars) and AP-1 (black bars) binding activity by EMSA
followed by densitometry. Data are representative of two
independent experiments.
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In a recent study on THP-1 macrophages, treatment with
ox-LDL for 3 days decreased mRNA expression of NF-κB
but increased that of c-jun[30]. Ox-LDL potentiated LPS-
induced TNF expression despite perturbing NF-κB activa-
tion [30], adding further support to the notion that major
changes in AP-1 levels are more predictive of changes in
TNF expression than minor effects on NF-κB.
Significant amounts of LDL can be taken up by macro-
phages without prior oxidation. In addition to uptake of
native LDL, aggregated LDL and complexes of LDL with
proteoglycans, matrix proteins, mast cell granules or anti-
bodies are efficiently taken up by macrophages [31]. Fur-
thermore, human monocyte-derived macrophages take
Figure 5
Specificity tests for NF-κB binding. EMSA was performed
using extracts from macrophages stimulated with TNF for 2
h. Unlabeled probe in excess (as indicated below) was used
as specific competitor. The mutant competitor (see Meth-
ods), had one point mutation in the NF-κB binding site. The
antibodies (2 µg/sample) were added after the radioactive
probe. After addition of antibodies, incubation was continued
for 1 h on ice. Lanes: 1, probe only; 2, control (TNF, 10 ng/
mL, 2 h); 3, specific competitor (50X excess); 4, specific com-
petitor (100X excess); 5, mutant competitor (50X excess); 6,
mutant competitor (100X excess); 7, anti-p65 (RelA); 8, anti-
p50 (NFKB1). The arrowheads indicate the positions of spe-
cific complexes. The bars mark supershifted bands. Data are
representative of four separate experiments.
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Figure 6
Specificity tests for AP-1 binding. EMSA was performed using
extracts from macrophages stimulated with TNF for 2 h.
Unlabeled probe in excess (as indicated below) was used as
specific competitor. The mutant competitor (see Methods),
had 2 point mutations in the AP-1 binding site, respectively.
The antibodies (2 µg/sample) were added after the radioac-
tive probe. After addition of antibodies, incubation was con-
tinued for 1 h on ice. Lanes: 1, probe only; 2, control (TNF,
10 ng/mL, 2 h); 3, specific competitor (20X excess); 4, spe-
cific competitor (40X excess); 5, mutant competitor (20X
excess); 6, mutant competitor (40X excess); 7, anti-c-Fos; 8,
anti-c-Jun (rabbit); 9, anti-c-Jun (goat); 10, anti-JunB; 11, anti-
JunD. The arrowheads indicate the positions of specific com-
plexes. The bars mark supershifted bands. Data are repre-
sentative of four separate experiments.
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up massive amounts of VLDL, which has been reported to
enter the vascular wall [32,33]. Another potential source
of non-oxidized lipid is the phagocytosis of cellular re-
mains and extracellular lipid deposits. It can thus be ar-
gued that substantial amounts of non-oxidized
lipoproteins are taken up by macrophages in the vascular
wall. The relative contribution of such lipid uptake to
foam cell formation in vivo is difficult to estimate. We
chose ac-LDL instead of VLDL as the means to load mac-
rophages with non-oxidized lipid, because these cells take
up VLDL so extensively that long treatments would prob-
ably kill the cells as a result of lipid overload.
Recently, patients with familial hypercholesterolemia
were reported to have significantly lower TNF production
in blood stimulated ex vivo by LPS, compared to normoli-
pidemic controls [34]. The study by Thai et al.[19] report-
ed suppressive effects of ac-LDL on the mRNA expression
of TNF, IL-1α, and MCP-1 in mouse peritoneal macro-
phages, as well as on macrophage-mediated tumor cytol-
ysis [19]. In other studies, ac-LDL and LDL have been
shown to inhibit natural killer (NK) cell function [35],
and both ox-LDL and LDL decreased TNF mRNA expres-
sion in NK cells [36], providing indirect support for the
concept that LDL uptake results in downregulation of the
inflammatory functions of monocytes/macrophages. It is
important to note that even though the immediate effect
of LDL uptake seems anti-inflammatory, accumulation of
lipoproteins and foam cells in the vascular wall indirectly
results in tissue damage and inflammation that can weak-
en the atherosclerotic plaque.
Conclusions
The present study shows that the inducibility of TNF ex-
pression decreases in lipid-loaded human macrophages.
Hence, uptake of LDL may have a suppressive effect on the
inflammatory potential of macrophages. The results im-
ply that foam cells in atherosclerotic plaques could con-
tribute less potently to an inflammatory reaction than
newly arrived monocytes/macrophages. Suppression of
inflammatory processes by cellular lipid accumulation
could play a protective role by down-regulation of the de-
structive activities of macrophages such as matrix degrada-
tion, production of oxidants and killing of smooth muscle
cells. On the other hand, if uptake of lipids promotes dif-
ferentiation of monocytes/macrophages into a more qui-
escent state, clearance of lipids trapped in the vascular
wall could decrease.
Methods
Reagents
[γ32P]ATP (185 TBq/mmol) was from Amersham Bio-
sciences (Buckinghamshire, UK). Antibodies against
NFKB1 (p50) and RelA (p65) were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). The oligonucle-
otides and antibodies for mobility shift assays of AP-1 and
NF-κB were obtained from Promega (Madison, WI) and
Santa Cruz Biotechnology. TNF and IL-1β were purchased
from R&D Systems (Minneapolis, MN). Ficoll-Paque and
Biotrak ELISA kits for TNF were purchased from Amer-
sham Biosciences and used according to the manufactur-
Figure 7
Lipid loading does not induce activation of PPAR-γ. Macro-
phages were cultured for 48 h in the presence of 5% LPDS ±
50 µg/mL LDL or ac-LDL. Half of the cells were then stimu-
lated with TNF (10 ng/mL) for 2 h. Nuclear extracts were
prepared and PPAR-γ binding activities were determined in
the extracts. The arrowhead indicates the position of specific
complexes. Lanes: 1, control; 2, TNF; 3, LDL; 4, LDL + TNF;
5, ac-LDL; 6, ac-LDL + TNF; 7, ox-LDL; 8, ox-LDL + TNF.
Similar data were obtained in three separate experiments.
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er's instructions. Nonidet P-40 was from Roche (Basel,
Switzerland).
Cell culture
Human peripheral blood monocytes were isolated from
buffy coats obtained from healthy blood donors. An equal
volume of PBS was added to the buffy coats. An amount
of dextran (6% stock solution) was then added corre-
sponding to 10% of the volume after addition of PBS. The
tubes were left to stand for 35 min, whereafter the upper
phase was transferred to new tubes and centrifuged at 200
g for 10 min. The supernatant was discarded and the pel-
lets resuspended in PBS. The centrifugation was repeated
twice, whereafter the cells were resuspended in 30 mL
PBS. The suspension was transferred to two new tubes (15
mL to each). 10 mL Ficoll-Paque was added underneath
the 15 mL suspensions, and the tubes were centrifuged at
400 g for 35 min. Leukocytes were collected from the in-
terface and pelleted by centrifugation at 400 g for 35 min.
Cells were resuspended in 50 mL PBS and counted. They
were centrifuged at 400 g for 10 min and resuspended in
an appropriate volume of Macrophage-SFM (Invitrogen
Life Technologies, Carlsbad, CA) culture medium supple-
mented with GM-CSF (10 ng/mL). 80 million cells were
added to 100 mm cell culture dishes. Two hours later, the
cells were rinsed three times with warm PBS containing
Ca2+ and Mg2+. Cells were then incubated over night in
Macrophage-SFM culture medium supplemented with
GM-CSF (10 ng/mL), transferrin (25 µg/mL) and gen-
tamicin (50 µg/mL). The medium was changed the fol-
lowing day, and subsequently every third day. Seven days
later, monocytes had differentiated into macrophages and
experiments or pretreatments without GM-CSF were start-
ed, as indicated in the text. Cell culture and preparation of
LDL were coordinated so that only fresh LDL and ac-LDL
(up to two weeks old) were used in the experiments.
Preparation of nuclear extract
Cells in 100 mm plastic dishes were rinsed with ice-cold
PBS and harvested in 5 mL PBS by scraping. Nuclear ex-
tracts were prepared essentially as described by Alksnis et
al[37]. The cells were washed with 1 mL PBS and resus-
pended in 100 µL hypotonic buffer (10 mmol/L Hepes,
pH 7.3, 10 mmol/L KCl, 1.5 mmol/L MgCl2, 1 mmol/L
dithiothreitol (DTT), 1 mmol/L phenylmethylsulfonyl
fluoride (PMSF)). After centrifugation, cells were lysed by
resuspension in 300 µL of lysis buffer (10 mmol/L Hepes,
pH 7.3, 10 mmol/L KCl, 1.5 mmol/L MgCl2, 0.4% Noni-
det P-40, 1 mmol/L DTT, 1 mmol/L PMSF, 1 µg/mL leu-
peptin, 15 µg/mL aprotinin). Following 10 min
incubation at 4°C, nuclei were collected by centrifugation
for 1 min at 8000 g. The pellets were washed once in 1 mL
of 20 mM KCl buffer (20 mmol/L Hepes, pH 7.3, 22%
glycerol, 20 mmol/L KCl, 1.5 mmol/L MgCl2, 0.2 mmol/
L EDTA, 1 mmol/L DTT, 1 mmol/L PMSF, 1 µg/mL leu-
peptin, 15 µg/mL aprotinin). The isolated nuclei were re-
suspended in 41 µL of 20 mmol/L KCl buffer, and 39 µL
of 600 mmol/L KCl buffer (20 mmol/L Hepes, pH 7.3,
22% glycerol, 0.6 mol/L KCl, 1.5 mmol/L MgCl2, 0.2
mmol/L EDTA, 1 mmol/L DTT, 1 mmol/L PMSF, 1 µg/mL
leupeptin, 15 µg/mL aprotinin) was added. Nuclear pro-
teins were extracted by incubation on ice for 30 min. After
centrifugation for 15 min at 8000 g, the supernatant con-
taining nuclear proteins was transferred to a precooled
microcentrifuge tube, and an aliquot of the extract was di-
luted 40 times with 300 mmol/L KCl buffer (mixture of
those above) for protein assay. Protein concentration was
determined spectrophotometrically [38] according to the
following equation: Protein concentration (µg/mL) = 184
× A(230 nm) – 81.7 × A(260 nm).
Electrophoretic mobility shift assay (EMSA)
Equal amounts of protein from nuclear extracts (1–3 µg)
were incubated on ice with 2 µg poly(dI-dC) and 1 µg
acetylated bovine serum albumin (BSA) in binding buffer
(giving the final concentrations stated below) for 10 min.
The oligonucleotide probe (50000 cpm in 5 µL) was add-
ed and the reaction mixture (25 µL) was incubated for 30
min at room temperature. Final concentrations in binding
reactions were as follows: 10% glycerol, 10 mmol/L Hepes
(pH 7.9), 60 mmol/L KCl, 5 mmol/L MgCl2, 0.5 mmol/L
EDTA, 1 mmol/L DTT, 1 mmol/L PMSF. DNA-protein
complexes were separated from unbound DNA probe on
native 7% polyacrylamide gels in low ionic strength buffer
(22.3 mmol/L Tris, 22.3 mmol/L borate, 0.5 mmol/L ED-
TA, pH 8). The sequences of the double-stranded oligonu-
cleotide probes labeled with T4 kinase and [γ32-P]ATP
were as follows: κB consensus: 5'-AGT TGA GGG GAC TTT
CCC AGG C-3'; κB mutant: 5'-AGT TGA GGC GAC TTT
CCC AGG C-3'; AP-1 consensus: 5'-CGC TTG ATG ACT
CAG CCG GAA-3'. AP-1 mutant: 5'-CGC TTG ATG ACT
TGG CCG GAA-3'. CD36 gene DR-1 site was used as
EMSA probe for PPAR-γ [7]: 5'-GGG GTC AGT AAG TCA
GAG GCC AGG GA-3'; PPAR-γ competitor: 5'-GGG GTC
AGT AAG TCA GTTTCAGGG A-3'.
Preparation of LDL
Blood was drawn from healthy volunteers into citric acid-
containing vials and plasma recovered by centrifugation
at 1400 g for 20 min at +1°C. The density of the isolated
plasma was adjusted to 1.019 kg/l by adding 28 µL of
0.760 mol/L (630.22 g/L) NaBr (density 1.46 g/mL at
20°C) to each mL of plasma. The plasma was centrifuged
at 50000 rpm (190000 g) for 20 h at +1°C in Beckman
Quick-Seal Bell-Top tubes in a Beckman 70 Ti rotor. Top
and bottom fractions were separated with a Beckman
Tube Slicer by cutting the tubes 3 cm from the top. The top
fraction (VLDL and IDL) was discarded. The density of the
bottom fraction was raised to 1.065 g/mL by adding 100
µL of 0.760 mol/L NaBr to each mL of the fraction. AfterBMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/13
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ultracentrifugation as above LDL was harvested as a top
fraction by cutting the tubes 1 cm from the top with the
tube slicer. The LDL was immediately sterile filtered (0.2
µm filter) and transferred to sterile dialysis tubing for sub-
sequent dialysis at 4°C against sterile PBS with 0.3 mmol/
L EDTA for 3 days, with two daily exchanges of the PBS.
The protein content of the LDL preparation was deter-
mined after dialysis and sterile filtration as described by
Lowry [39].
Acetylation of LDL
1 mL of 0.91 mol/L (100 mg/mL) N-acetylimidazole in
phosphate buffer was added to 3 mL of LDL (typical pro-
tein concentration 7 mg/mL) in 100 mmol/L sodium
phosphate, 100 mmol/L KCl, pH 7.4, at 0°C. After 15
min, the reaction was stopped by passing the reaction
mixture over Sephadex G-50 (BIO-RAD Econo-Pac 10 DG
column). The acetylated LDL was then dialyzed at 4°C
against PBS, 0.3 mmol/L EDTA, for 3–5 days prior to use.
Lipid uptake was confirmed in all the experiments by the
clearly visible presence of large amounts of lipid in cell
lysates after treatments with ac-LDL but not after control
treatments without lipoproteins. Lipid uptake was quanti-
tated by high-performance thin-layer chromatography
(HP-TLC), which showed that the cellular lipid content/
total protein (µg/mg) increased after treatment with ac-
LDL (50 µg/mL, 48 h) as follows: cholesteryl ester 87 (ac-
LDL) vs. 29 (control) (200% increase compared to con-
trol); triacylglycerol 56 vs. 24 (133% increase); unesteri-
fied cholesterol 57 vs. 51 (12% increase);
phosphatidylcholine 36 vs. 36 (unchanged).
Oxidation of LDL
Copper oxidation was performed by incubation (37°C,
5% CO2) of LDL in the presence of 5 µmol/L CuSO4 for
the times indicated, typically 15 h. To determine thiobar-
bituric acid reactive substances (TBARS), lipoprotein sam-
ples (0.1 mL) were incubated in a boiling water bath for
15 min with 0.1 mL of 1 mmol/L ferric chloride, 0.1 mL
of 1 mmol/L butylated hydroxytoluene (BHT), 1.5 mL of
0.2 mol/L glycine buffer (pH 3.6) and 1.5 mL of 3.5
mmol/L thiobarbituric acid (TBA) supplemented with
0.3% SDS. After cooling to room temperature, the pink
chromogen was extracted[40] with acetic acid (1 mL) and
chloroform (2 mL). The optical density of the upper layer
was measured at 532 nm against a water blank. 1,1,3,3-
Tetraethoxypropane (TEP) was used as a standard. Values
< 2 nmol TEP equivalents/mg of protein were obtained for
non-oxidized LDL, while ox-LDL had values of 20 to 30
nmol TEP equivalents/mg of protein.
Northern Blotting
Poly(A+)RNA was isolated using the MicroFastTrack kit
(Invitrogen) utilizing oligo(dT) cellulose. 2 µg of the
mRNA was electrophoresed in formaldehyde/1.3% agar-
ose gels and transblotted to nylon membranes. The blots
were hybridized with 32P-end-labeled probes with a spe-
cific activity approximately 35 × 109 cpm/µg. The cDNA
probe encoding TNF was a 1196 bp fragment cleaved
from a pBR322 derived vector obtained from Chiron Cor-
poration (Emeryville, CA). Prehybridization was done at
42°C for 6 h. Hybridizations were done overnight at 42°C
in a commercial hybridization solution (NorthernMax,
Ambion, Austin, Texas) containing 0.1 mg/mL salmon
sperm DNA and 2 ng of probe per mL. After hybridiza-
tion, blots were washed twice in 2X SSPE, 0.1% SDS at
room temperature for 45 min, twice in 2X SSPE, 2% SDS
at 65°C for 45 min, and twice in 0.1X SSPE, 0.1% SDS at
room temperature for 15 min. The membranes were then
rinsed in 2X SSPE and wrapped in saran wrap before scan-
ning using a Fujifilm BAS-1500 phosphorimager and sub-
sequent exposure to Amersham Hyperfilm MP film with
an intensifying screen at -70°C.
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